Corus’ presence at the Dental Tribune’s IDS 2023

CENTOGENE is partnering with IQVIA to improve health outcomes for rare disease patients

Corus expands into the UK with the integration of Byrnes Dental Laboratory

Corus grows in Spain with the acquisition of two laboratories in Seville and Madrid

Centogene reaches 12,500 patient milestone in world’s largest observational study on Parkinson’s disease genetics

Corus expands into Scandinavia with the integration of Nordentic, the region’s largest player in dental technology

Centogene and Agios expand partnership for clinical development of PYRUKYND® (mitapivat) to treat children with rare blood disease

Centogene and Takeda extend market access and expansion partnership to advance patient care globally

Sophie Wilford, Qovetia’s Director of Marketing and Communication, launched a webinar addressed to veterinarians